Surgery Prevails as Initial Therapy for mRCC
Patients with untreated metastatic renal cell carcinoma (mRCC) had significantly better survival with surgery rather than targeted therapy as the initial treatment, a retrospective review of 15,000 patients showed.08/17/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 17, 2018 Category: Urology & Nephrology Source Type: news
Testing turns up heavy metals in baby food; what Consumer Reports says parents need to know
Testing of dozens of the most popular packaged foods for babies and toddlers turned up noticeable and even “worrisome” levels of lead and other heavy metals, according to the watchdog Consumer Reports.
Over the course of a child's development, exposure to heavy metals increases the likelihood of developing cancer, particularly lung cancer, bladder cancer and kidney cancer, and increases the risks of issues with neurological development,08/17/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 17, 2018 Category: Urology & Nephrology Source Type: news
Cabozantinib In mRCC
In this video, doctors discuss Cabozantinib in mRCC.08/16/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 16, 2018 Category: Urology & Nephrology Source Type: news
Disease Progression In Patients With Metastatic RCC
This video discusses disease progression in patients with metastatic RCC.08/15/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 15, 2018 Category: Urology & Nephrology Source Type: news
Robots An Increasing Presence In Maine Operating Rooms
Robots now assist surgeons with kidney cancer, difficult hernias and gynecologic cancers. Robot-assisted surgeries have the best outcomes and are most justified for hard-to-reach areas of the body, such as for prostate removal and head and neck surgeries, according to a 2016 study published in The Milbank Quarterly, a scholarly journal.08/14/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 14, 2018 Category: Urology & Nephrology Source Type: news
New Blood Test Could Predict Kidney Cancer 5 Years Before Diagnosis
According to a study, a blood test could predict kidney cancer risk and survival, five years prior to its diagnosis.08/13/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 13, 2018 Category: Urology & Nephrology Source Type: news
https://www.sierraclub.org/sierra/PFAS-toxin-every-household-states-sue-chemical-companies
Medical studies have linked PFAS in drinking water to kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, pancreatic cancer and birth defects.08/13/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 13, 2018 Category: Urology & Nephrology Source Type: news
Ways To Keep Your Kidneys Healthy
Kidneys are one of the most important organs in our body. Kidneys helps with the metabolism of the body, regulated blood volume and pressure, makes red blood cells, keeps the bones strong and gets rid of the all the waste accumulated in our bodies. Our unhealthy lifestyle and strenuous lives put the kidneys under stress and they become susceptible to kidney stones, infections, cysts, tumor, and a kidney failure.08/10/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 10, 2018 Category: Urology & Nephrology Source Type: news
British Scientists Identify Kidney Cancer's Cellular Origin
Researchers from Wellcome Sanger Institute, the University of Cambridge and the University of Newcastle discovered that adult renal carcinoma cells are a version of a specific rare subtype of healthy adult kidney cell, called PT1. They found that despite genetic differences, all the renal carcinoma cells studied had developed the same PT1 characteristics. These results could provide the basis of a new method for treating cancer by targeting the PT1 cell specifically.08/10/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 10, 2018 Category: Urology & Nephrology Source Type: news
Renal Cell Carcinoma and Myelodysplastic Syndrome Show Epigenetic Association
Hypermethylation has been documented in some myeloid disorders including myelodysplastic syndrome (MDS) and in renal cell carcinoma (RCC). A group at the Mayo Clinic noticed the epigenetic marking patterns between these vastly different conditions and wondered if there was a connection. The group found that there was a strong association.08/09/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 9, 2018 Category: Urology & Nephrology Source Type: news
Asheville Firefighter's Line-Of-Duty Death Could Set Precedent For Death Benefits
Asheville firefighter Will Willis died of kidney cancer earlier this year. The Asheville Citizen-Times first reported that for just the second time in such cases, the North Carolina Industrial Commission decided it was a line-of-duty death.08/09/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 9, 2018 Category: Urology & Nephrology Source Type: news
Biomarkers May Predict TKI Response In Metastatic RCC
Angiogenesis-related biomarkers regulated by hypoxia were found to be strong predictors of primary renal tumor response (PRT), progression-free survival (PFS), and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC) who were being treated with sunitinib prior to kidney removal, according to research published in Clinical Cancer Research.108/08/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 8, 2018 Category: Urology & Nephrology Source Type: news
Sunitinib vs Nephrectomy Followed By Sunitinib In Metastatic Renal Cell Carcinoma
In an interim analysis of the French phase III noninferiority Carmena trial reported in The New England Journal of Medicine, M éjean et al found that sunitinib alone was not inferior in overall survival vs nephrectomy followed by sunitinib in patients with intermediate- or poor-risk metastatic clear cell renal cell carcinoma.08/08/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 8, 2018 Category: Urology & Nephrology Source Type: news
Results From The Carmena Trial
Arnaud M éjean, MD, PhD, of the Hôpital Européen Georges Pompidou, discusses his study’s potentially practice-changing finding that nephrectomy is no longer the standard of care for patients with metastatic renal cell carcinoma (Abstract LBA3).08/08/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 8, 2018 Category: Urology & Nephrology Source Type: news
VEGF TKI + Immunotherapy Combinations For mRCC
This video discusses strategies for metastatic renal cell carcinoma that involve I-O therapies in combination with VEGF-targeted therapies.08/08/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 8, 2018 Category: Urology & Nephrology Source Type: news
